CMOs Take Center Stage as Biopharmaceutical Industry Embraces Outsourcing
The global Biopharmaceutical Contract Manufacturing Organization (CMO) Market Size, valued at USD 15.3 billion in 2023, is projected to reach an impressive USD 58.2 billion by 2032, growing at a remarkable CAGR of 16.0% during the forecast period 2024 to 2032, according to the latest research report.
As the biopharmaceutical industry continues to evolve, outsourcing manufacturing services has...
0 Comments
0 Shares